The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...

Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...

Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...

From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...

Continuous chromatography is poised to become an increasingly important part of monoclonal antibody manufacturing strategies.

Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...

Rationalizing Biological Drug Development: Biosimilar Science, Modality-Specific Pathways, and the Bioprocessing Revolution, Part 1 Regulatory frameworks for biosimilars were developed two decades ago ...

HPLC continues to meet such demands through advances in column chemistry, instrument performance, and software, allowing laboratories to characterize increasingly complex molecules with greater ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large molecule formats.